Cargando…

CCAT2 is an oncogenic long non-coding RNA in pancreatic ductal adenocarcinoma

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is highly aggressive with poor prognosis. Long non-coding RNAs (lncRNAs), a group of non-coding RNAs, play important roles in the progression of PDAC. This study aimed to investigate the potential involvement of lncRNA CCAT2 in PDAC tumorigenesis....

Descripción completa

Detalles Bibliográficos
Autores principales:	Cai, Yi, Li, Xiaomei, Shen, Peng, Zhang, Dong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5751927/ https://www.ncbi.nlm.nih.gov/pubmed/29298720 http://dx.doi.org/10.1186/s40659-017-0149-0

Ejemplares similares

CCAT 1- A Pivotal Oncogenic Long Non-Coding RNA in Colorectal Cancer
por: Liau, Xiew Leng, et al.
Publicado: (2023)

Long Non-Coding RNA CCAT2 Activates RAB14 and Acts as an Oncogene in Colorectal Cancer
por: Wang, Dalu, et al.
Publicado: (2021)

Long Non-coding RNA CCAT1 Acts as an Oncogene and Promotes Sunitinib Resistance in Renal Cell Carcinoma
por: Shan, Liping, et al.
Publicado: (2020)

Melittin-induced long non-coding RNA NONHSAT105177 inhibits proliferation and migration of pancreatic ductal adenocarcinoma
por: Wang, Xinjing, et al.
Publicado: (2018)

Long non-coding RNA CCAT2 functions as an oncogene in hepatocellular carcinoma, regulating cellular proliferation, migration and apoptosis
por: ZHOU, NING, et al.
Publicado: (2016)

Corrigendum: Long non-coding RNA CCAT1 acts as an oncogene and promotes sunitinib resistance in renal cell carcinoma
por: Shan, Liping, et al.
Publicado: (2023)

Analysis of long non-coding RNA expression profiles in pancreatic ductal adenocarcinoma
por: Fu, Xue-Liang, et al.
Publicado: (2016)

Long noncoding RNA CCAT1 acts as an oncogene and promotes chemoresistance in docetaxel-resistant lung adenocarcinoma cells
por: Chen, Jing, et al.
Publicado: (2016)

A Long Non-coding RNA Signature to Improve Prognostic Prediction of Pancreatic Ductal Adenocarcinoma
por: Zhou, Chenhao, et al.
Publicado: (2019)

Non-coding RNAs in Pancreatic Ductal Adenocarcinoma
por: Gong, Ruining, et al.
Publicado: (2020)

Roles of Long Non-Coding RNA CCAT2 in Cervical Cancer Cell Growth and Apoptosis
por: Wu, Le, et al.
Publicado: (2016)

Knockdown of long non-coding RNA CCAT2 suppressed proliferation and migration of glioma cells
por: Guo, Hua, et al.
Publicado: (2016)

Microbiome and MicroRNA or Long Non-Coding RNA—Two Modern Approaches to Understanding Pancreatic Ductal Adenocarcinoma
por: Izdebska, Wiktoria Maria, et al.
Publicado: (2023)

The long non-coding RNA CCAT2 is up-regulated in ovarian cancer and associated with poor prognosis
por: Huang, Shuying, et al.
Publicado: (2016)

VIRMA-Dependent N6-Methyladenosine Modifications Regulate the Expression of Long Non-Coding RNAs CCAT1 and CCAT2 in Prostate Cancer
por: Barros-Silva, Daniela, et al.
Publicado: (2020)

Long non-coding RNA CERS6-AS1 facilitates the oncogenicity of pancreatic ductal adenocarcinoma by regulating the microRNA-15a-5p/FGFR1 axis
por: Yun, Zhennan, et al.
Publicado: (2021)

CCAT2, a novel long non-coding RNA in breast cancer: expression study and clinical correlations
por: Redis, Roxana S, et al.
Publicado: (2013)

Vitamin D Suppresses Ovarian Cancer Growth and Invasion by Targeting Long Non-Coding RNA CCAT2
por: Wang, Liye, et al.
Publicado: (2020)

Increased expression of long non-coding RNA CCAT2 predicts poorer prognosis in patients with hepatocellular carcinoma
por: Fu, Changbo, et al.
Publicado: (2019)

Identification of FEZ2 as a potential oncogene in pancreatic ductal adenocarcinoma
por: Yang, Chaozhi, et al.
Publicado: (2022)

Prognostic value of long non-coding RNA CCAT1 expression in patients with cancer: A meta-analysis
por: Shi, Deyao, et al.
Publicado: (2017)

Clinicopathological and prognostic value of long non-coding RNA CCAT1 expression in patients with digestive system cancer
por: Yu, Yue, et al.
Publicado: (2023)

CCAT: Combinatorial Code Analysis Tool for transcriptional regulation
por: Jiang, Peng, et al.
Publicado: (2014)

Enhancer-derived long non-coding RNAs CCAT1 and CCAT2 at rs6983267 has limited predictability for early stage colorectal carcinoma metastasis
por: Thean, Lai Fun, et al.
Publicado: (2021)

Long non-coding RNAs CCAT1 and CCAT2 in colorectal liver metastases are tumor-suppressive via MYC interaction and might predict patient outcomes
por: Franz, Clemens, et al.
Publicado: (2023)

shRNA targeting long non-coding RNA CCAT2 controlled by tetracycline-inducible system inhibits progression of bladder cancer cells
por: Li, Jianfa, et al.
Publicado: (2016)

Long noncoding RNA CCAT2 promotes breast tumor growth by regulating the Wnt signaling pathway
por: Cai, Yi, et al.
Publicado: (2015)

Long non-coding RNA in pancreatic adenocarcinoma and pancreatic neuroendocrine tumors
por: Moschovis, Dimitrios, et al.
Publicado: (2017)

Alternative polyadenylation drives oncogenic gene expression in pancreatic ductal adenocarcinoma
por: Venkat, Swati, et al.
Publicado: (2020)

Long non-coding RNA CCAT1 modulates neuropathic pain progression through sponging miR-155
por: Dou, Lidong, et al.
Publicado: (2017)

Correction: Prognostic value of long non-coding RNA CCAT1 expression in patients with cancer: A meta-analysis
por: Shi, Deyao, et al.
Publicado: (2017)

Knockdown of long non-coding RNA CCAT2 suppresses the progression of thyroid cancer by inhibiting the Wnt/β-catenin pathway
por: Xin, Suping, et al.
Publicado: (2020)

Long non-coding RNA CCAT2 promotes prostate cancer cell proliferation and invasion by regulating the Wnt/β-catenin signaling pathway
por: He, Peng, et al.
Publicado: (2020)

Upregulation of long noncoding RNA CCAT1-L promotes epithelial–mesenchymal transition in gastric adenocarcinoma
por: Fang, Hua, et al.
Publicado: (2018)

Long non-coding RNA CCAT1 as a diagnostic and prognostic molecular marker in various cancers: a meta-analysis
por: Zhang, Zhihui, et al.
Publicado: (2018)

Expression of Concern: Prognostic value of long non-coding RNA CCAT1 expression in patients with cancer: A meta-analysis
Publicado: (2023)

Long noncoding RNA MIR31HG exhibits oncogenic property in pancreatic ductal adenocarcinoma and is negatively regulated by miR-193b
por: Yang, H, et al.
Publicado: (2016)

MicroRNA-664 targets paired box protein 6 to inhibit the oncogenicity of pancreatic ductal adenocarcinoma
por: Wang, Qi, et al.
Publicado: (2022)

Identification and characterization of the gene expression profiles for protein coding and non-coding RNAs of pancreatic ductal adenocarcinomas
por: Gutiérrez, María Laura, et al.
Publicado: (2015)

eIF4A supports an oncogenic translation program in pancreatic ductal adenocarcinoma
por: Chan, Karina, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0hlr6jbhuf3skc46i4r8u3efl4